Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma

August 19, 2022

Primary Outcome Measures

disease free survival or time to recurrence [ Time Frame: Through out the whole study with maximum of 2 years ]
time from clearance of disease till onset of recurrence of same disease
overall survival [ Time Frame: till mortality of the case or 2 years maximum ]
survival of the cases till mortality

Secondary Outcome Measures

comorbidities [ Time Frame: Through out the whole study duration with maximum of two years ]
complications that may encounter either pre , intra or post intervention

Inclusion Criteria

patients presented with localised MPM are the main target and histopathological diagnosis of MPM is made via video-assisted thoracoscopic surgery or open multiple pleural biopsies.

Exclusion Criteria

patients with stage III or IV MPM in which cytoreductive surgery has no role.
Patients underwent extrapleural pneumonectomy (EPP) as a cytoreductive surgery , because we are focusing on P/D only either conventional P/D or extended P/D

CONTACT INFORMATION

Name*

First Last

Email*

Phone*

Address*

Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country

Have you received a diagnosis?*

Yes

DIAGNOSIS

Diagnosis?*

Date of Diagnosis*

Comments*

Name

This field is for validation purposes and should be left unchanged.

Quick Facts

Accepts Healthy Volunteers
Ages Available for Study
ClinicalTrials.gov Identifier
Collaborators
Contacts(s)
Location(s)
Estimated Enrollment
Estimated Study Start Date
Estimated Primary Completion Dates
Full Title
Genders Eligible for Study
Investigator(s)
Last Updated
Other Contact